MTOR and psoriasis: In addition, not only the clinical symptoms of psoriasis, such as erythema, thickening, and scaling, but also the skin inflammation cytokines are alleviated through the downregulation of p-phosphoinositide 3-kinase (PI3K) and p-mTOR by treatment with MC-EO in a mouse model of IMQ-induced psoriasis [70].